Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for KAPA is 6.14M and currently, short sellers hold a 0.11% of that float. On November 18, 2024, KAPA’s average trading volume was 433.17K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
KAPA) stock’s latest price update
Kairos Pharma Ltd (AMEX: KAPA)’s stock price has dropped by -24.59 in relation to previous closing price of 2.06. Nevertheless, the company has seen a gain of 15.67% in its stock price over the last five trading days. globenewswire.com reported 2024-10-22 that LOS ANGELES, Oct. 22, 2024 (GLOBE NEWSWIRE) — Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announced today that John S. Yu, M.D., Chief Executive Officer, will present a corporate overview at the LD Micro Main Event XVII. The conference is being held on October 28 – 30, 2024 at the Luxe Sunset Boulevard Hotel in Los Angeles.
KAPA’s Market Performance
The volatility ratio for the week is 37.53%, and the volatility levels for the past 30 days are at 16.46% for KAPA. The simple moving average for the past 20 days is 3.14% for KAPA’s stock, with a -3.86% simple moving average for the past 200 days.
KAPA Trading at -3.86% from the 50-Day Moving Average
After a stumble in the market that brought KAPA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -61.25% of loss for the given period.
Volatility was left at 16.46%, however, over the last 30 days, the volatility rate increased by 37.53%, as shares surge +4.72% for the moving average over the last 20 days.
During the last 5 trading sessions, KAPA rose by +15.67%, in comparison to the 20-day moving average, which settled at $1.50. In addition, Kairos Pharma Ltd saw -40.38% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for KAPA
Equity return is now at value -375.74, with -92.10 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 2.84.
Conclusion
To wrap up, the performance of Kairos Pharma Ltd (KAPA) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
